Home › NDC Lookup › RxCUI directory › RxCUI 2123190

1.17 ML romosozumab-aqqg 89.7 MG/ML Prefilled Syringe [Evenity] — RxCUI 2123190

Name: 1.17 ML romosozumab-aqqg 89.7 MG/ML Prefilled Syringe [Evenity] (RxCUI 2123190)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 2123190 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2123190

Official name1.17 ML romosozumab-aqqg 89.7 MG/ML Prefilled Syringe [Evenity]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known as1.17 ML Evenity 89.7 MG/ML Prefilled Syringe; Evenity 105 MG in 1.17 mL Prefilled Syringe; Evenity 105 MG per 1.17 ML Prefilled Syringe

FDA products mapped3

Package NDCs mapped3

Reported Medicaid activity (SDUD)14,773 prescriptions · 47 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Romosozumab-aqqg Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Evenity works in a unique way — it actually helps your body build new bone, not just slow down bone loss. It does this by blocking a protein called sclerostin, which normally limit...
What exactly does Evenity do for my bones?
Yes — Evenity's bone-building effect is strongest in the first several months and gradually wanes over the 12-month course. After 12 doses, the anabolic (bone-building) benefit has...
Why is the treatment only 12 months? Does it stop working?

📖 Read our full Romosozumab-aqqg Injection guide →

🕸️ Concept Web — How 1.17 ML romosozumab-aqqg 89.7 MG/ML Prefilled Sy... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 1.17 ML romosozumab-aqqg 89.7 MG/ML Prefilled Syringe [Evenity] RxCUI 2123190 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Romosozumab 2123126 IN
- Romosozumab-aqqg 2123180 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Evenity 2123186 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Romosozumab Prefilled Syringe 2123183 SCDF
- Romosozumab-aqqg Prefilled Syringe 2646186 SCDFP
- Romosozumab Injectable Product 2123182 SCDG
- Romosozumab-aqqg Injectable Product 2659502 SCDGP
- Romosozumab Prefilled Syringe [Evenity] 2123188 SBDF
- Romosozumab-aqqg Prefilled Syringe [Evenity] 2657679 SBDFP
- Evenity Injectable Product 2123189 SBDG
- Prefilled Syringe 721656 DF
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- 1.17 ML romosozumab-aqqg 89.7 MG/ML Prefilled Syringe 2123184 SCD
- Romosozumab-aqqg 89.7 MG/ML 2123181 SCDC
- Romosozumab-aqqg 89.7 MG/ML [Evenity] 2123187 SBDC
Packs 2

Fixed collections of drugs packaged and sold together, like dose packs.
- {2 (1.17 ML romosozumab-aqqg 89.7 MG/ML Prefilled Syringe [Evenity]) } Pack [Evenity 210 MG Dose] 2123191 BPCK
- {2 (1.17 ML romosozumab-aqqg 89.7 MG/ML Prefilled Syringe) } Pack 2123185 GPCK

Showing up to 8 concepts per family — 16 of 17 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

1.17 ML romosozumab-aqqg 89.7 MG/ML Prefilled Syringe SCD · 2123184
{2 (1.17 ML romosozumab-aqqg 89.7 MG/ML Prefilled Syringe) } Pack GPCK · 2123185
Romosozumab-aqqg 89.7 MG/ML SCDC · 2123181
Romosozumab Prefilled Syringe SCDF · 2123183
Romosozumab-aqqg Prefilled Syringe SCDFP · 2646186
Romosozumab Injectable Product SCDG · 2123182
Romosozumab-aqqg Injectable Product SCDGP · 2659502

Brand-Name Concepts

{2 (1.17 ML romosozumab-aqqg 89.7 MG/ML Prefilled Syringe [Evenity]) } Pack [Evenity 210 MG Dose] BPCK · 2123191
Romosozumab-aqqg 89.7 MG/ML [Evenity] SBDC · 2123187
Romosozumab Prefilled Syringe [Evenity] SBDF · 2123188
Romosozumab-aqqg Prefilled Syringe [Evenity] SBDFP · 2657679
Evenity Injectable Product SBDG · 2123189
Evenity BN · 2123186

📦 FDA Products & Package NDCs

3 products · 3 package NDCs

3 package NDCs map to RxCUI 2123190 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
55513-0509-02	2 SYRINGE, GLASS in 1 CARTON (55513-509-02) / 1.17 mL in 1...	Evenity	Amgen, Inc	2026-01-09
55513-0880-02	2 SYRINGE in 1 CARTON (55513-880-02) / 1.17 mL in 1 SYRINGE...	Evenity	Amgen, Inc	2019-04-09
55513-0998-02	2 SYRINGE, GLASS in 1 CARTON (55513-998-02) / 1.17 mL in 1...	Evenity	Amgen, Inc	2024-07-01

Observed labelers: Amgen, Inc (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J3111	Inj. romosozumab-aqqg 1 mg	2	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.